Home » Topics » Regulatory » Patents

Patents
RSS

Recent patents disclose new therapeutic agents for anxiety, depression, etc.

Aug. 23, 2006

Recent Dainippon patent describes new treatment option for cardiovascular disorders

Aug. 23, 2006

Novel agents for thrombotic disorders disclosed in recent Astellas patent

Aug. 22, 2006

Novel antiinfective agents disclosed in recent patent literature

Aug. 22, 2006

Novel treatment options for metabolic disorders described in recent Merck and Dainippon patents

Aug. 22, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

Aug. 22, 2006

Recent Tibotec and Pfizer patents report novel therapeutic agents for HIV infection

Aug. 21, 2006

Recent Tanabe and Dainippon patents describe new antidiabetic agents

Aug. 21, 2006

Recent Tanabe and Neurogen patents report novel analgesic agents

Aug. 21, 2006

New imaging agents for ocular disorders and cancer disclosed in recent GE and Yeda patents

Aug. 21, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...